Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.
Clinical trial NCT02445976 · COMPLETED
Trial details
- NCT number
- NCT02445976
- Sponsor
- Innocrin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2018-12-01
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.